From Venom-to-Vial-to-Pill: The Translational Journey of GLP-1 Peptides and the Evolving Landscape of Biopharmaceutics Modeling From Venom-to-Vial-to-Pill: The Translational Journey of GLP-1 Peptides and the Evolving Landscape of Biopharmaceutics Modeling ABSTRACT Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become an important therapeutic option for metabolic disorders
Antigenic structure of poliovirus in inactivated vaccines
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis
Melanotan II is also caught by WADA category S0
The adoption of plant-based L-Glutathione also facilitates compliance with evolving regulations in Europe and North America, where natural ingredients are favored
Lane DJR, Ayton S, Bush AI